Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint
β Scribed by Y. Agid; E. Ahlskog; A. Albanese; D. Calne; T. Chase; J. De Yebenes; S. Factor; S. Fahn; O. Gershanik; C. Goetz; W. Koller; M. Kurth; A. Lang; A. Lees; P. Lewitt; D. Marsden; E. Melamed; P. P. Michel; Y. Mizuno; J. Obeso; W. Oertel; W. Olanow; W. Poewe; P. Pollak; S. Przedzorski; N. Quinn; R. Raisman-Vozari; A. Rajput; F. Stocchi; E. Tolosa
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 21 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro